secwatch.observer — SEC 8-K summary
======================================

Issuer:     VASO Corp (VASO)
CIK:        0000839087
Form:       8-K
Filed at:   2025-11-20T23:59:59+00:00
Accession:  0001213900-25-112966
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaso sells VasoHealthcare IT to Nano-X for up to $800K; <5% of total revenue
----------------------------------------------------------------------------

- Sale consideration up to $800K: $200K at closing, $600K earnout tied to post-close performance.
- VasoHealthcare IT represented less than 5% of Vaso's total revenue; proceeds to fund other business lines.
- Transaction expected to close within weeks; Vaso engaged Barley Snyder as legal counsel.
- Divestiture follows strategic review; CEO cites sharper focus on core operations as reason.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/839087/000121390025112966/0001213900-25-112966-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/839087/000121390025112966/ea0266535-8k_vaso.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-112966

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer